TTN and familial dilated cardiomyopathy: For example, siRNA-mediated knockdown of MTSS1 in iPSC-CMs derived from patients with DCM due to TTN truncating variants has been shown to enhance contractile function, suggesting a potential therapeutic avenue [144].